Trials / Conditions / Advanced Solid Tumor (Phase 1)
Advanced Solid Tumor (Phase 1)
5 registered clinical trials studyying Advanced Solid Tumor (Phase 1) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors NCT07434609 | Nanolattix Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Soli NCT07123415 | Aptabio Therapeutics, Inc. | Phase 1 |
| Recruiting | EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors NCT07163325 | Epics Therapeutics | Phase 1 |
| Recruiting | A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NCT06527300 | Zhejiang Wenda Pharma Technology LTD. | Phase 2 |
| Completed | A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors NCT06208124 | Immuneering Corporation | Phase 1 / Phase 2 |